Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 03-2015 | 03-2014 | 03-2013 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,512 | 7,464 | 6,942 | 369 | 668 |
| Receivables | 1,530 | 1,446 | 732 | 665 | 397 |
| Inventories | 3,294 | 3,032 | 1,933 | 1,358 | 305 |
| TOTAL | $16,714 | $12,331 | $9,925 | $2,543 | $1,498 |
| Non-Current Assets | |||||
| PPE Net | 8,111 | 6,402 | 4,200 | 4,029 | 4,285 |
| Investments And Advances | 0 | 0 | 3,329 | 3,329 | 3,329 |
| Intangibles | 6,412 | 6,382 | 6,350 | 694 | 643 |
| Other Non-Current Assets | 438 | 806 | 514 | 529 | 557 |
| TOTAL | $14,960 | $13,590 | $14,393 | $8,582 | $8,814 |
| Total Assets | $31,674 | $25,920 | $24,318 | $11,125 | $10,312 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 549 | 475 | 3,404 | 3,391 | 3,398 |
| Accounts payable and accrued liabilities | 1,804 | 3,384 | 2,215 | 1,325 | 1,067 |
| Accrued Expenses | 555 | 614 | N/A | 28 | 71 |
| TOTAL | $4,640 | $5,069 | $6,161 | $5,357 | $4,549 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,176 | 2,065 | 0 | N/A | N/A |
| Deferred Revenues | 1,013 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 54,702 | 53,392 | 99,216 | 14,289 | 20,581 |
| TOTAL | $60,156 | $55,582 | $99,355 | $14,441 | $20,746 |
| Total Liabilities | $64,796 | $60,651 | $105,516 | $19,799 | $25,295 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 726,487 | 658,419 | 568,042 | 394,580 | 346,217 |
| Common Shares | 712 | 631 | 560 | 375 | 332 |
| Retained earnings | -142,665 | -141,982 | -225,007 | -128,431 | -129,919 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $-33,122 | $-34,731 | $-81,198 | $-8,673 | $-14,984 |
| Total Liabilities And Equity | $31,674 | $25,920 | $24,318 | $11,125 | $10,312 |